Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis

Open access

Abstract

STUDY QUESTION: Can a panel of plasma protein biomarkers be identified to accurately and specifically diagnose endometriosis? SUMMARY ANSWER: A novel panel of 10 plasma protein biomarkers was identified and validated, demonstrating strong predictive accuracy for the diagnosis of endometriosis. WHAT IS KNOWN ALREADY: Endometriosis poses intricate medical challenges for affected individuals and their physicians, yet diagnosis currently takes an average of 7 years and normally requires invasive laparoscopy. Consequently, the need for a simple, accurate non-invasive diagnostic tool is paramount. STUDY DESIGN, SIZE, DURATION: This study compared 805 participants across two independent clinical populations, with the status of all endometriosis and symptomatic control samples confirmed by laparoscopy. A proteomics workflow was used to identify and validate plasma protein biomarkers for the diagnosis of endometriosis. PARTICIPANTS/MATERIALS, SETTING, METHODS: A proteomics discovery experiment identified candidate biomarkers before a targeted mass spectrometry assay was developed and used to compare plasma samples from 464 endometriosis cases, 153 general population controls, and 132 symptomatic controls. Three multivariate models were developed: Model 1 (logistic regression) for endometriosis cases versus general population controls, Model 2 (logistic regression) for rASRM stage II to IV (mild to severe) endometriosis cases versus symptomatic controls, and Model 3 (random forest) for stage IV (severe) endometriosis cases versus symptomatic controls. MAIN RESULTS AND THE ROLE OF CHANCE: A panel of 10 protein biomarkers were identified across the three models which added significant value to clinical factors. Model 3 (severe endometriosis vs symptomatic controls) performed the best with an area under the receiver operating characteristic curve (AUC) of 0.997 (95% CI 0.994–1.000). This model could also accurately distinguish symptomatic controls from early-stage endometriosis when applied to the remaining dataset (AUCs ≥0.85 for stage I to III endometriosis). Model 1 also demonstrated strong predictive performance with an AUC of 0.993 (95% CI 0.988–0.998), while Model 2 achieved an AUC of 0.729 (95% CI 0.676–0.783). LIMITATIONS, REASONS FOR CAUTION: The study participants were mostly of European ethnicity and the results may be biased from undiagnosed endometriosis in controls. Further analysis is required to enable the generalizability of the findings to other populations and settings. WIDER IMPLICATIONS OF THE FINDINGS: In combination, these plasma protein biomarkers and resulting diagnostic models represent a potential new tool for the non-invasive diagnosis of endometriosis. STUDY FUNDING/COMPETING INTEREST(S): Subject recruitment at The Royal Women’s Hospital, Melbourne, was supported in part by funding from the Australian National Health and Medical Research Council (NHMRC) project grants GNT1105321 and GNT1026033 and Australian Medical Research Future Fund grant no. MRF1199715 (P.A.W.R., S.H.-C., and M.H.). Proteomics International has filed patent WO 2021/184060 A1 that relates to endometriosis biomarkers described in this manuscript; S.B., R.L., and T.C. declare an interest in this patent. J.I., S.B., C.L., D.I., H.L., K.P., M.D., M.M., M.R., P.T., R.L., and T.C. are shareholders in Proteomics International. Otherwise, the authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/deae278

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow diagram of biomarker identification proteomics workflow. MRM, multiple reaction monitoring.
Figure 1. Flow diagram of biomarker identification proteomics workflow. MRM, multiple reaction monitoring.CC BY-NC · PubMed Central
Figure 2. Receiver operating characteristic curves for Models 1, 2, and 3. Model 1: all endometriosis n = 443 versus general population controls n = 147, Model 2: endometriosis (stages II–IV) n = 212 versus symptomatic controls n = 130, and Model 3: endometriosis (stage IV) n = 89 versus symptomatic controls n = 130. Only participants with complete data were included in each model.
Figure 2. Receiver operating characteristic curves for Models 1, 2, and 3. Model 1: all endometriosis n = 443 versus general population controls n = 147, Model 2: endometriosis (stages II–IV) n = 212 versus symptomatic controls n = 130, and Model 3: endometriosis (stage IV) n = 89 versus symptomatic controls n = 130. Only participants with complete data were included in each model.CC BY-NC · PubMed Central
Figure 3. Receiver operating characteristic curves for Model 3: endometriosis (stage IV) versus symptomatic controls applied to all rASRM stages. Stage I: n = 241, stage II: n = 65, stage III: n = 58, and stage IV: n = 89. Only participants with complete data were included in this modeling.
Figure 3. Receiver operating characteristic curves for Model 3: endometriosis (stage IV) versus symptomatic controls applied to all rASRM stages. Stage I: n = 241, stage II: n = 65, stage III: n = 58, and stage IV: n = 89. Only participants with complete data were included in this modeling.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. Ito, 2019, Biomarkers of Endometriosis
  2. Lipscombe, Endometriosis Biomarkers (Patent WO2021184060A1).

Cited by

  • Steroid hormone profiling reveals altered adrenal androgen production in endometriosis

    Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag109 · Cited by 1

    “24 Similarly, an undisclosed panel of salivary miRNAs has been reported to detect endometriosis with high sensitivity but whether any of these markers vary across different populations, endometriosis subtypes or menstrual cycle stage is still unknown.”

See all 27

Metadata

Authors
Schoeman, E. M., Bringans, S., Peters, K., Casey, T., Andronis, C., Chen, L., Duong, M., Girling, J. E., Healey, M., Boughton, B. A., Ismail, D., Ito, J., Laming, C., Lim, H., Mead, M., Raju, M., Tan, P., Lipscombe, R., Holdsworth-Carson, S., & Rogers, P. A. W.
Affiliations
  • Proteomics International , Nedlands, WA,
  • Royal Women's Hospital (AU)
  • La Trobe University (AU)
  • Department of Obstetrics and Gynecology, University of Melbourne and Gynecology Research Centre, Royal Women’s Hospital , Melbourne, VIC,
Corresponding author
Peters, K
Venue
Human Reproduction
Published
2024-12-24
Volume
40
Issue
2
Pages
270-279
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W4405753240
Cited by
27
References
35
Citations by year
2026: 17 · 2025: 10
FWCI
10.58
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
Funders
  • The Royal Women’s Hospital
  • National Health and Medical Research Council (GNT1105321, GNT1026033)
  • Medical Research Future (MRF1199715)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
endometriosis, plasma protein biomarkers, non-invasive diagnosis, biomarker panel, endometriosis staging, random forest, logistic regression, proteomics, diagnostic accuracy, symptom management, biomarker validation, biomarker discovery
MeSH terms
Adult, Blood Proteins, Endometriosis, Female, Humans, Middle Aged, Models, Statistical, Biomarkers, Case-Control Studies, Proteomics, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis. https://app.cochat.ai/papers/10.1093/humrep/deae278
The paper
Schoeman, E. M., Bringans, S., Peters, K., Casey, T., Andronis, C., Chen, L., Duong, M., Girling, J. E., Healey, M., Boughton, B. A., Ismail, D., Ito, J., Laming, C., Lim, H., Mead, M., Raju, M., Tan, P., Lipscombe, R., Holdsworth-Carson, S., & Rogers, P. A. W. (2025). Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis. Human Reproduction. https://doi.org/10.1093/humrep/deae278

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.